Hepalatide for Injection

· Shanghai HEP Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hepalatide for Injection, covering 2025-12-23 to 2025-12-23. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D [Phase 2]